129 related articles for article (PubMed ID: 31588689)
1. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
[TBL] [Abstract][Full Text] [Related]
2. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166
[TBL] [Abstract][Full Text] [Related]
3. Study on the mechanism of S100A4-mediated cancer oncogenesis in uveal melanoma cells through the integration of bioinformatics and in vitro experiments.
Chen H; Zhang W; Shi J; Tang Y; Chen X; Li J; Yao X
Gene; 2024 Jun; 911():148333. PubMed ID: 38431233
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells.
Vertuani S; Dubrovska E; Levitsky V; Jager MJ; Kiessling R; Levitskaya J
Cancer Immunol Immunother; 2007 Feb; 56(2):193-204. PubMed ID: 16752155
[TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma cell lines Mel270 and 92.1 exhibit a mesenchymal phenotype and sensitivity to the cytostatic effects of transforming growth factor beta in vitro.
Doudnikoff C; Leclerc D; Angenard G; Gilot D; Coulouarn C; Mouriaux F
Mol Vis; 2024; 30():160-166. PubMed ID: 38601020
[TBL] [Abstract][Full Text] [Related]
6. Dose-Dependent Carbon-Dot-Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism.
Ding Y; Yu J; Chen X; Wang S; Tu Z; Shen G; Wang H; Jia R; Ge S; Ruan J; Leong KW; Fan X
Adv Sci (Weinh); 2021 Apr; 8(8):2002404. PubMed ID: 33898168
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications.
Loda A; Semeraro F; Parolini S; Ronca R; Rezzola S
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189104. PubMed ID: 38701937
[TBL] [Abstract][Full Text] [Related]
8. Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract][Full Text] [Related]
9. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
10. Uveal and conjunctival melanomas: disease course and outcomes in Chinese patients.
Chan JYY; Lam SC; Yuen HKL
Hong Kong Med J; 2023 Dec; 29(6):506-513. PubMed ID: 38044329
[TBL] [Abstract][Full Text] [Related]
11. Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma.
Al Balushi K; Al Hadhrami A; Balushi HA; Al Lawati A; Das S
Curr Drug Targets; 2024; 25(3):149-157. PubMed ID: 38115619
[TBL] [Abstract][Full Text] [Related]
12. Modulation of AMPK Significantly Alters Uveal Melanoma Tumor Cell Viability.
Deliktas O; Gedik ME; Koc I; Gunaydin G; Kiratli H
Ophthalmic Res; 2023; 66(1):1230-1244. PubMed ID: 37647867
[TBL] [Abstract][Full Text] [Related]
13. Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent conditions.
Goyeneche AA; Lasiste JME; Abdouh M; Bustamante P; Burnier JV; Burnier MN
Cancer Cell Int; 2024 May; 24(1):180. PubMed ID: 38783299
[TBL] [Abstract][Full Text] [Related]
14. Identifying biomarkers and novel therapeutic targets in uveal melanoma.
Wessely A; Koch EAT; Vera J; Berking C; Heppt MV
J Dtsch Dermatol Ges; 2024 Jan; 22(1):29-32. PubMed ID: 37902386
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival.
Dewaele S; Delhaye L; De Paepe B; de Bony EJ; De Wilde J; Vanderheyden K; Anckaert J; Yigit N; Nuytens J; Vanden Eynde E; Smet J; Verschoore M; Nemati F; Decaudin D; Rodrigues M; Zhao P; Jochemsen A; Leucci E; Vandesompele J; Van Dorpe J; Marine JC; Van Coster R; Eyckerman S; Mestdagh P
Oncogene; 2022 Jan; 41(1):15-25. PubMed ID: 34508176
[TBL] [Abstract][Full Text] [Related]
16. The multiple roles of autophagy in uveal melanoma and the microenvironment.
Liu B; Yao X; Shang Y; Dai J
J Cancer Res Clin Oncol; 2024 Mar; 150(3):121. PubMed ID: 38467935
[TBL] [Abstract][Full Text] [Related]
17. Targeting the β
Satilmis H; Verheye E; Vlummens P; Oudaert I; Vandewalle N; Fan R; Knight JM; De Beule N; Ates G; Massie A; Moreaux J; Maes A; De Bruyne E; Vanderkerken K; Menu E; Sloan EK; De Veirman K
J Pathol; 2023 Jan; 259(1):69-80. PubMed ID: 36245401
[TBL] [Abstract][Full Text] [Related]
18. Is Uveal Melanoma a Hormonally Sensitive Cancer? A Review of the Impact of Sex Hormones and Pregnancy on Uveal Melanoma.
Miller M; Schoenfield L; Abdel-Rahman M; Cebulla CM
Ocul Oncol Pathol; 2021 Sep; 7(4):239-250. PubMed ID: 34604195
[TBL] [Abstract][Full Text] [Related]
19. The Burden of Histologically Confirmed Uveal Melanoma in Aotearoa-New Zealand: A 21-year Review of the National Cancer Registry.
Lim JZ; Gokul A; Misra SL; Hadden PW; Cavadino A; McGhee CNJ
Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):384-391. PubMed ID: 37523430
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adverse effects induced by tebentafusp in patients with metastatic uveal melanoma: a case series and treatment insights.
Rodriguez I; Norman T; Guenther J; Smart K; Kwong A; Berry J; In GK; Worswick S
Clin Exp Dermatol; 2024 Mar; 49(4):392-394. PubMed ID: 37956104
[No Abstract] [Full Text] [Related]
[Next] [New Search]
